Nanoviricides, Inc. SEC filings NNVC
Nanoviricides, Inc. has 556 filings in SEC EDGAR's recent list, going back to Nov 14, 2006. Its latest annual report, Form 10-K, was filed on Sep 28, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (officer or director change). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 8, 2026 | Nov 21, 2026 |
| DEF 14A | Proxy statement | Oct 8, 2025 | Nov 8, 2025 |
| DEF 14A | Proxy statement | Oct 15, 2024 | Dec 7, 2024 |
| DEF 14A | Proxy statement | Dec 4, 2023 | Jan 13, 2024 |
| DEFA14A | Additional proxy material | Dec 23, 2022 | — |
| DEF 14A | Proxy statement | Nov 15, 2022 | Dec 17, 2022 |
| PRE 14A | Preliminary proxy statement | Nov 4, 2022 | Nov 4, 2022 |
| DEF 14A | Proxy statement | Oct 12, 2021 | Nov 20, 2021 |
| DEF 14A | Proxy statement | Oct 26, 2020 | Dec 5, 2020 |
| DEF 14A | Proxy statement | Feb 19, 2020 | Mar 16, 2020 |
| PRE 14A | Preliminary proxy statement | Feb 5, 2020 | Mar 12, 2020 |
| DEF 14A | Proxy statement | Oct 28, 2019 | Dec 7, 2019 |
| PRE 14A | Preliminary proxy statement | Oct 16, 2019 | Oct 15, 2019 |
| DEF 14A | Proxy statement | Oct 19, 2018 | Nov 30, 2018 |
| DEF 14A | Proxy statement | Oct 27, 2017 | Dec 8, 2017 |
| DEF 14A | Proxy statement | Oct 28, 2016 | Dec 11, 2016 |
| DEF 14A | Proxy statement | Dec 8, 2015 | Jan 23, 2016 |
| DEF 14A | Proxy statement | Dec 5, 2014 | Jan 23, 2015 |
| PRE 14A | Preliminary proxy statement | Nov 17, 2014 | Nov 17, 2014 |
| DEF 14A | Proxy statement | Oct 22, 2013 | Dec 9, 2013 |
| DEF 14A | Proxy statement | Dec 4, 2012 | Jan 16, 2013 |
| DEF 14C | Information statement | Apr 20, 2009 | Apr 20, 2009 |
| PRE 14C | Nanoviricides pre 14c 4-8-2009 | Apr 8, 2009 | Apr 8, 2009 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NNVC (NYSE)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Shelton, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1379006
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.